Imagine if we could trick the body into fighting liver diseases better.
That’s what a team of scientists at the University of Barcelona believe might be possible, after they discovered the crucial role of a protein called RNF41.
Their research suggests it could offer a new way to treat chronic liver conditions such as cirrhosis and inflammation.
Meet the RNF41 Protein
The RNF41 protein is related to inflammation, the body’s way of fighting against things that harm it, like injuries or infections.
In a healthy body, there’s a careful balance of inflammation. Too little, and your body can’t fight off harmful things.
But too much inflammation, or inflammation that lasts a long time, can cause problems, including liver diseases.
The scientists found that people with liver cirrhosis, a disease where the liver becomes very scarred and can’t work properly, had lower levels of the RNF41 protein in certain immune cells from their liver.
The same was true for mice with a liver disease called fibrosis, where the liver becomes scarred.
The researchers think that long-lasting inflammation might be to blame for the drop in RNF41.
The good news is that when they managed to restore the RNF41 protein in mice, it reduced the scarring, cut inflammation, and helped the liver to start repairing itself.
How They Made the Discovery
To uncover the importance of the RNF41 protein, the researchers used a new technique involving special nanoparticles, tiny particles that are so small, millions of them could fit on the head of a pin.
These nanoparticles can have useful properties for medical research.
The team designed theirs to work in a specific way and combined them with a method to isolate certain immune cells, using magnetic beads tied to antibodies, a type of protein the immune system uses to fight invaders.
With these techniques, they were able to show that their nanoparticles can deliver gene therapy to the right immune cells in a scarred liver.
Next Steps for RNF41
The team also found that in fibrotic mouse livers, if the RNF41 protein goes away in these immune cells, it triggers a flood of inflammatory signals leading to more scarring, liver damage and some death.
“This tells us that the RNF41 protein is crucial to fight fibrosis and chronic inflammation in liver disease,” says lead researcher Pedro Melgar-Lesmes.
The next step is to work out which proteins control RNF41 in the immune cells. This could help them to create new drugs to increase the levels of this key protein.
“It’s all about understanding the role these immune cells play in inflammation and liver fibrosis,” Melgar-Lesmes explains.
“If we can increase the expression of this key protein, we could potentially control the role of these cells in liver disease.”
This groundbreaking research opens the door to a new way to tackle chronic liver diseases. It gives us hope that by targeting the RNF41 protein, we could tip the balance of inflammation in the body, helping to combat these conditions.
If you care about liver health, please read studies about a diet that can treat fatty liver disease and obesity, and coffee drinkers may halve their risk of liver cancer.
For more information about liver health, please see recent studies that anti-inflammatory diet could help prevent fatty liver disease, and results showing vitamin D could help prevent non-alcoholic fatty liver disease.
The study was published in Science Translational Medicine.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
